72:. Such progress has been supported by the development of DIABCARE (and its analogue QUALIDIAB as it is known in French and Spanish), an integrated information system to monitor diabetes care, according to the “gold standards” of the St Vincent Declaration Action Program. The first platform of its type for medical quality evaluation across Europe, then emulated in the Americas, it has served as a model for other chronic noncommunicable diseases and for other WHO regions. For example, this approach has been applied more recently in several Asian countries, including South Korea, Thailand, Indonesia, Malaysia, and India. Similar work has emerged from Nigeria. In Sweden, a National Diabetes Registry established in response to the St Vincent Declaration, continues to provide a tool for continuous quality assurance in diabetes care: a 2014 report notes that the original purpose, to monitor the results of performance of health centres from year to year and to compare these with national and regional means, is still the most important one, while follow-up of guidelines, treatments and complications are as important at a national level.
88:
relevance of process-related targets to achieve short to medium term success; the value of broadly based participation in gaining recognition of a major cause of disease burden at national health policy level; wide acceptance of an integrated program model; and the critical role of having a
Ministry staff member designated in each country as a managerial focal point. The initiative stimulated development of national guidelines to improve clinical management, diabetes education and nutrition, the defining of minimum acceptable standards of care, enhanced regional training and information sharing, and the implementation in several countries of a quality of care management system.
56:
Strategy for Sub-Saharan Africa (2006). Taken collectively, these partnerships are of additional interest because, given the participation of several biomedical industry entities as co-signatories and financial contributors, they were a precursor and provided valuable learning for today’s many international and global health and development partnerships. Perhaps most importantly, these initiatives fostered the development of national diabetes programs in their respective regions. Significantly, they were also accompanied by action plans with varying levels of complexity, for example, for the WPDD this included commitment to planning, monitoring and evaluation.
92:
on non-communicable diseases. In the 5th edition, the estimated number of adults living with diabetes is given as 366 million, representing 8.3% of the global adult population. This number is projected to increase to 552 million people by 2030, or 9.9% of adults. These estimates are considerably higher than those reported in the 4th edition, largely due to new data from China, the Middle East, and Africa.
79:/WHO and IDF after two 5 year planning and implementation periods. Since then, PAHO has built instead on the CARMEN network of integrated national NCD initiatives, conceived in 1995 and implemented in 1997, and the Pan American Forum for Action on NCDs (PAFNCDs), launched in 2009. Both initiatives include diabetes in a set of major
91:
In 2012, the
International Diabetes Federation released the 5th edition of the IDF Diabetes Atlas. In this it is noted that estimates published in the 4th edition were instrumental in providing the evidence to drive the unanimous adoption of the resolution for the September 2011 UN High-level Meeting
640:
Mohan V, Shah SN, Joshi SR, Seshiah V, Sahay BK, Banerjee S, Wangnoo SK, Kumar A, Kalra S, Unnikrishnan A G, Sharma SK, Rao P V, Akhtar S, Shetty RV, Das AK, "On Behalf of the DiabCare India 2011 Study Group. Current status of management, control, complications and psychosocial aspects of patients
561:
Likitmaskul S, Wacharasindhu S, Rawdaree P, Ngarmukos C, Deerochanawong C, Suwanwalaikorn S, Chetthakul T, Bunnag P, Kosachunhanun N, Plengvidhaya N, Leelawatana R, Krittiyawong S, Benjasuratwong Y, Pratipanawatr T (Aug 2006). "Thailand diabetes registry project: type of diabetes, glycemic control
59:
The
Declaration put forward a set of programmatic targets to which all member counties would aspire, and significant successes have been documented: for example, in 2006 it was reported that the St. Vincent Declaration target of reducing diabetes related blindness by one third appears to have been
55:
The St
Vincent Declaration has inspired other regional partnerships between the IDF and WHO, especially in response to the emerging pandemic of type 2 diabetes: the Declaration of the Americas or DOTA (1996), the Western Pacific Declaration on Diabetes (WPDD 2000), and the Declaration and Diabetes
810:
Peruga A. Conjunto de
Acciones para la Reducion Multifactorial de las Enfermedades non Transmissibles. In: Worldwide Efforts to Improve Heart Health: a follow up to the Catalonia Declaration selected program descriptions. Washington: US Department of Health and Human Services, Centers for Disease
87:
of DOTA found that it met its short term targets in most countries: preparation of national estimates of disease burden, development and implementation of national strategies and plans to deal with diabetes, and recognition of diabetes as a public health problem. Useful lessons emerged: the
48:(IDF) Europe. General standards for diabetes care were agreed on, as well as plans for improving care in participating countries toward the goals. Twenty years later, in 2009, it was stated in an editorial in the
387:
Krans HMJ, Porta M, Keen H. Diabetes care and research in Europe: the St
Vincent Declaration action programme implementation document. Copenhagen, WHO Regional Office for Europe, 1992.
52:
that 'despite the progress made following the St. Vincent
Declaration and the UN Resolution, significant gaps still exist and urgent action is needed to stem this rising epidemic'.
397:
Bandurska-Stankiewicz E., Wiatr D. (2006). "Diabetic blindness significantly reduced in the Warmia and Mazury regions of Poland: Saint
Vincent Declarations target achieved".
214:
King H, Rewers M (Jan 1993). "Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc
Diabetes Reporting Group".
49:
257:
Amos AF, McCarty DJ, Zimmet P (1997). "The rising global burden of diabetes and its complications: estimates and projections to the year 2010".
270:
75:
The St
Vincent’s, Western Pacific and Africa initiatives remain fully in force, but DOTA was discontinued as a joint venture of
754:
442:
Gagliardino JJ, Hera M, Siri F (2001). "Evaluación de la calidad de la asistencia al paciente diabético en América Latina".
111:
101:
45:
399:
130:
The Saint Vincent Declaration on diabetes care and research in Europe. Acta diabetologia. 1989, 10 (Suppl) 143-144.
659:"Profile of Nigerians with diabetes mellitus - Diabcare Nigeria study group (2008) Results of a multicenter study"
614:
Mafauzy M, Hussein Z, Chan SP (Aug 2011). "The status of diabetes control in Malaysia: results of DiabCare 2008".
583:"The DiabCare Asia 2008 study – Outcomes on control and complications of type 2 diabetic patients in Indonesia"
477:
Piwernetz K (2001). "DIABCARE Quality Network in Europe - a model for quality management in chronic diseases".
939:
28:
published as the product of an international conference held in St. Vincent, Italy, on 10–12 October 1989.
84:
80:
41:
959:
772:"Developing effective and affordable models for noncommunicable disease prevention and control"
708:
Eliasson B, Gudbjornsdotirr S (2014). "Diabetes care -- improvement through measurement".
8:
926:
International Diabetes Atlas 4th edition. International Diabetes Federation (IDF). 2012.
657:
Chinenye S, Uloko AE, Ogbera AO, Ofoegbu EN, Fasanmade OA, Fasanmade AA, Ogbu OO (2012).
562:
and prevalence of microvascularcomplications in children and adolescents with diabetes".
337:"The status of national diabetes programmes: A global survey of IDF member associations"
863:
846:
685:
658:
538:
513:
424:
317:
239:
191:
174:
106:
37:
721:
581:
Soewondo P, Soegondo S, Suastika K, Pranoto A, Soeatmadji DW, Tjokroprawiro A (2010).
375:
Action Plan for the Western Pacific Declaration on Diabetes: From Evidence to Action.
36:
Representatives of government health departments and patients' organizations from all
954:
909:
868:
793:
750:
725:
690:
623:
543:
494:
490:
459:
416:
358:
309:
274:
231:
196:
25:
904:
887:
455:
428:
376:
321:
243:
899:
858:
783:
717:
680:
670:
645:
594:
533:
525:
486:
451:
408:
348:
301:
266:
223:
186:
153:
353:
336:
744:
412:
142:"Diabetes - from St. Vincent to Glasgow, Have we progressed in 20 years ?"
529:
305:
948:
292:
King H, Aubert RF, Herman WH (1998). "Global burden of diabetes, 1995-2025".
227:
158:
141:
788:
771:
675:
913:
872:
797:
729:
694:
627:
599:
582:
547:
498:
463:
420:
362:
200:
313:
278:
271:
10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.0.CO;2-R
235:
833:
560:
21:
514:"Diabcare Asia 2001-Korea country report on outcome data and analysis"
641:
with diabetes in India: Results from the DiabCare India 2011 Study.
396:
175:"WHO and the International Diabetes Federation: Regional Partners"
139:
821:
580:
69:
65:
61:
888:"The Pan American Health Organization and World Diabetes Day"
76:
743:
White, Franklin; Stallones, Lorann; Last, John M. (2013).
656:
512:
Rhee SY, Kim YS, Oh S, Choi WH, Park JE, Jeong WJ (2005).
847:"Status of national diabetes programmes in the Americas"
811:
Control and Prevention and Health Promotion, June 1997.
707:
334:
441:
742:
613:
832:Pan American Forum for Action on NCDs (PAFNCDs).
377:http://www.idf.org/webdata/docs/WPDD_PoA_2010.pdf
256:
40:met with diabetes experts under the aegis of the
946:
646:http://www.ijem.in/preprintarticle.asp?id=129715
291:
146:British Journal of Diabetes and Vascular Disease
50:British Journal of Diabetes and Vascular Disease
885:
83:. Its discontinuance by PAHO notwithstanding,
511:
746:Global Public Health: Ecological Foundations
820:Pan American Health Organization – CARMEN.
476:
844:
213:
140:Felton Anne-Marie, Hall Michael S (2009).
903:
862:
787:
684:
674:
598:
537:
352:
190:
157:
335:Colagiuri R, Short R, Buckley A (2010).
769:
341:Diabetes Research and Clinical Practice
947:
172:
834:http://new.paho.org/panamericanforum/
940:Text of the St. Vincent Declaration
112:National Diabetes Education Program
13:
14:
971:
933:
102:Epidemiology of diabetes mellitus
46:International Diabetes Federation
491:10.1097/00004850-200104003-00002
400:British Journal of Ophthalmology
920:
905:10.1590/s1020-49892001001100001
879:
838:
826:
814:
804:
763:
736:
701:
650:
634:
607:
574:
554:
505:
470:
456:10.1590/S1020-49892001001100003
435:
390:
381:
369:
328:
285:
250:
207:
166:
133:
124:
1:
886:Barcelo A, Vovides Y (2001).
722:10.1016/S0168-8227(14)70732-6
354:10.1016/j.diabres.2009.10.005
117:
7:
822:http://new.paho.org/carmen/
749:. Oxford University Press.
95:
10:
976:
413:10.1177/112067210601600510
31:
20:is a set of goals for the
845:White F, Nanan D (1999).
663:Indian J Endocrinol Metab
530:10.3904/kjim.2005.20.1.48
306:10.2337/diacare.21.9.1414
85:monitoring and evaluation
81:non-communicable diseases
42:World Health Organization
479:Int Clin Psychopharmacol
228:10.2337/diacare.16.1.157
159:10.1177/1474651409341318
892:Rev Panam Salud Publica
851:Bull World Health Organ
710:Diabetes Res Clin Pract
676:10.4103/2230-8210.98011
444:Rev Panam Salud Publica
179:Bull World Health Organ
18:St. Vincent Declaration
600:10.13181/mji.v19i4.412
789:10.1093/ije/30.6.1494
643:Indian J Endocr Metab
44:(WHO) Europe and the
716:(Suppl 2): S291–4.
518:Korean J Intern Med
485:(Suppl 3): S5–13.
265:(Suppl 5): S1–85.
107:World Diabetes Day
38:European countries
756:978-0-19-975190-7
570:(Suppl 1): S10–6.
26:diabetes mellitus
967:
927:
924:
918:
917:
907:
883:
877:
876:
866:
842:
836:
830:
824:
818:
812:
808:
802:
801:
791:
770:White F (2001).
767:
761:
760:
740:
734:
733:
705:
699:
698:
688:
678:
654:
648:
638:
632:
631:
611:
605:
604:
602:
578:
572:
571:
564:J Med Assoc Thai
558:
552:
551:
541:
509:
503:
502:
474:
468:
467:
439:
433:
432:
394:
388:
385:
379:
373:
367:
366:
356:
332:
326:
325:
300:(9): 1414–1431.
289:
283:
282:
254:
248:
247:
211:
205:
204:
194:
170:
164:
163:
161:
137:
131:
128:
60:achieved in the
975:
974:
970:
969:
968:
966:
965:
964:
945:
944:
936:
931:
930:
925:
921:
884:
880:
857:(12): 981–987.
843:
839:
831:
827:
819:
815:
809:
805:
776:Int J Epidemiol
768:
764:
757:
741:
737:
706:
702:
655:
651:
639:
635:
612:
608:
587:Med J Indonesia
579:
575:
559:
555:
510:
506:
475:
471:
440:
436:
395:
391:
386:
382:
374:
370:
333:
329:
290:
286:
255:
251:
212:
208:
173:King H (1999).
171:
167:
138:
134:
129:
125:
120:
98:
34:
24:of people with
12:
11:
5:
973:
963:
962:
960:1989 documents
957:
943:
942:
935:
934:External links
932:
929:
928:
919:
898:(5): 297–299.
878:
837:
825:
813:
803:
762:
755:
735:
700:
669:(4): 558–564.
649:
633:
616:Med J Malaysia
606:
573:
553:
504:
469:
450:(5): 309–317.
434:
389:
380:
368:
347:(2): 137–142.
327:
284:
249:
206:
165:
132:
122:
121:
119:
116:
115:
114:
109:
104:
97:
94:
33:
30:
9:
6:
4:
3:
2:
972:
961:
958:
956:
953:
952:
950:
941:
938:
937:
923:
915:
911:
906:
901:
897:
893:
889:
882:
874:
870:
865:
860:
856:
852:
848:
841:
835:
829:
823:
817:
807:
799:
795:
790:
785:
782:(6): 1494–5.
781:
777:
773:
766:
758:
752:
748:
747:
739:
731:
727:
723:
719:
715:
711:
704:
696:
692:
687:
682:
677:
672:
668:
664:
660:
653:
647:
644:
637:
629:
625:
622:(3): 175–81.
621:
617:
610:
601:
596:
593:(4): 235–44.
592:
588:
584:
577:
569:
565:
557:
549:
545:
540:
535:
531:
527:
523:
519:
515:
508:
500:
496:
492:
488:
484:
480:
473:
465:
461:
457:
453:
449:
445:
438:
430:
426:
422:
418:
414:
410:
406:
402:
401:
393:
384:
378:
372:
364:
360:
355:
350:
346:
342:
338:
331:
323:
319:
315:
311:
307:
303:
299:
295:
294:Diabetes Care
288:
280:
276:
272:
268:
264:
260:
253:
245:
241:
237:
233:
229:
225:
222:(1): 157–77.
221:
217:
216:Diabetes Care
210:
202:
198:
193:
188:
184:
180:
176:
169:
160:
155:
152:(4): 142–44.
151:
147:
143:
136:
127:
123:
113:
110:
108:
105:
103:
100:
99:
93:
89:
86:
82:
78:
73:
71:
67:
63:
57:
53:
51:
47:
43:
39:
29:
27:
23:
19:
922:
895:
891:
881:
854:
850:
840:
828:
816:
806:
779:
775:
765:
745:
738:
713:
709:
703:
666:
662:
652:
642:
636:
619:
615:
609:
590:
586:
576:
567:
563:
556:
524:(1): 48–54.
521:
517:
507:
482:
478:
472:
447:
443:
437:
407:(5): 722–7.
404:
398:
392:
383:
371:
344:
340:
330:
297:
293:
287:
262:
258:
252:
219:
215:
209:
182:
178:
168:
149:
145:
135:
126:
90:
74:
58:
54:
35:
17:
15:
185:(12): 954.
68:regions of
22:health care
949:Categories
259:Diabet Med
118:References
955:Diabetes
914:11774800
873:10680245
798:11821370
730:25550056
695:22837916
628:22111435
548:15906953
499:11459330
464:11774802
429:33156014
421:17061224
363:19914727
322:41600108
244:38239691
201:10680241
96:See also
864:2557777
686:3401756
539:3891412
314:9727886
279:9450510
236:8123057
192:2557774
32:History
912:
871:
861:
796:
753:
728:
693:
683:
626:
546:
536:
497:
462:
427:
419:
361:
320:
312:
277:
242:
234:
199:
189:
70:Poland
66:Mazury
62:Warmia
425:S2CID
318:S2CID
240:S2CID
910:PMID
869:PMID
794:PMID
751:ISBN
726:PMID
691:PMID
624:PMID
544:PMID
495:PMID
460:PMID
417:PMID
359:PMID
310:PMID
275:PMID
232:PMID
197:PMID
77:PAHO
64:and
16:The
900:doi
859:PMC
784:doi
718:doi
714:106
681:PMC
671:doi
595:doi
534:PMC
526:doi
487:doi
452:doi
409:doi
349:doi
302:doi
267:doi
224:doi
187:PMC
154:doi
951::
908:.
896:10
894:.
890:.
867:.
855:77
853:.
849:.
792:.
780:30
778:.
774:.
724:.
712:.
689:.
679:.
667:16
665:.
661:.
620:66
618:.
591:19
589:.
585:.
568:89
566:.
542:.
532:.
522:20
520:.
516:.
493:.
483:16
481:.
458:.
448:10
446:.
423:.
415:.
405:16
403:.
357:.
345:87
343:.
339:.
316:.
308:.
298:21
296:.
273:.
263:14
261:.
238:.
230:.
220:16
218:.
195:.
183:77
181:.
177:.
148:.
144:.
916:.
902::
875:.
800:.
786::
759:.
732:.
720::
697:.
673::
630:.
603:.
597::
550:.
528::
501:.
489::
466:.
454::
431:.
411::
365:.
351::
324:.
304::
281:.
269::
246:.
226::
203:.
162:.
156::
150:9
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.